● The Challenge: Many new drug compounds, particularly in oncology, have poor water solubility, leading to low bioavailability and reduced effectiveness. ● The Solution: Amorphous Solid Dispersion (ASD) is a proven formulation technology that disperses a drug molecule within a polymer matrix, creating a stable amorphous form.
● Our Expertise: Amorphyx Pharmatech is bringing this advanced technology to Bangladesh and the global market. We specialize in converting anti-cancer APIs into ASD form, dramatically improving their solubility and therapeutic potential.
● Benefits: ○ Enhanced drug solubility and dissolution rate. ○ Increased bioavailability. ○ Improved patient outcomes with potentially lower doses.
● Partner: We collaborate with Crystal Pharmatech for ASD development services.